# Lexicon Pharmaceuticals, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Lexicon Pharmaceuticals, Inc.](/companies/lxrx.md) (CIK 1062822)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 07:33 ET
- Period: 2025-11-06
- Accession: 0001062822-25-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000049/lxrx-20251106.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000049/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1062822/000106282225000049/lxrx-20251106.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001062822-25-000049. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.